<PAGE>
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 8, 2001
------------------------------------------------------
Date of report (Date of earliest event reported)
GALAGEN INC.
--------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-27976 41-1719104
------------------------- ------------------------- --------------------
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
301 Carlson Parkway , Suite 301
Minnetonka, Minnesota 55305
--------------------------------------------- -----------------------------
(Address of Principal Executive Offices) (Zip Code)
Telephone Number: (952) 258-5500
-----------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
================================================================================
<PAGE>
ITEM 5. OTHER EVENTS.
As January 8, 2001, shares of common stock of GalaGen Inc. (the
"Company") began trading on the Over-the-Counter Bulletin Board under the symbol
"GGEN." Shares of the Company's common stock had been listed on the Nasdaq
SmallCap Market.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: January 11, 2001
GALAGEN INC.
(Registrant)
By /s/ Franklin L. Kuhar
------------------------------------------
Franklin L. Kuhar
Vice President, Chief Financial Officer
and Treasurer
(Principal financial and accounting
officer and duly authorized signatory
on behalf of the registrant)
